This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

Special Issue: Cell Signaling Pathways as Novel Drug Targeting Platforms

Edited by

Seyed Mohammad Nabavi (Baqiyatallah University of Medical Sciences)

Special Issue: Cell Signaling Pathways as Novel Drug Targeting Platforms

Published: May 2019

Volume 1443

Published since 1824, Annals of the New York Academy of Sciences is the Academy’s premier scientific publication.

Learn More

CONCISE REVIEWS

Effects of phytochemicals on thyroid function and their possible role in thyroid disease

Francesca Pistollato, Manuel Masias, Pablo Agudo, Francesca Giampieri, Maurizio Battino

Advantages and disadvantages of apoptosis in the aging process

Sandro Argüelles, Angélica Guerrero‐Castilla, Mercedes Cano, Mario F. Muñoz, Antonio Ayala

 

REVIEWS

Targeting LOX‐1 in atherosclerosis and vasculopathy: current knowledge and future perspectives

Kunming Tian, Sayoko Ogura, Peter J. Little, Suo‐wen Xu, Tatsuya Sawamura

The Wnt signaling pathway: a potential therapeutic target against cancer

Noyel Ghosh, Uday Hossain, Ankita Mandal, Parames C. Sil

The role of melatonin in targeting cell signaling pathways in neurodegeneration

Mayuri Shukla, Vorapin Chinchalongporn, Piyarat Govitrapong, Russel J. Reiter